Pancreatitis is therefore a distinctive form of inflammation, in which NF-κB plays a central role and may therefore be amenable to biologic therapies, such as inhibitors of cytokines or their receptors (e.g., anti-IL-6, IL-1Rα, anti-TNF) [117]. Here, NFKB1 is linked to pancreatitis.